Mecwins announced today that a new method for digitally counting nanoparticles has been granted by the United States Patent Office and the European Patent Office.
The patent, entitled “Method for optically detecting biomarkers” (Patent US11519856B2 and EP3719477B1), provides a method for detecting biomarkers in a biosensor that includes acquiring spatially and spectrally resolved images, correcting the data to reduce noise, locating particles in the images, characterizing each particle, classifying the particles, counting the particles for each class, and calculating an overall analysis result for each biomarker in each sample. This is done using a statistical value based on the number of particles per class for all images acquired from the same sample.